Post your job infront of 100,000+ qualified LP's and GP's.
Portfolio Analyst
Recently Filled Jobs
Sponsored
Texas PSF - Investment Operations Analyst Job lp
Texas Permanent School Fund
Austin, TX ,United States of America
Investment Analyst - Real Estate Job lp
Alaska Permanent Fund Corporation
Juneau or Anchorage, AK ,United States of America
Investment Analyst - Real Estate Job lp
Alaska Permanent Fund Corporation
Juneau, AK; Anchorage, AK ,United States of America
Investment Risk Analyst Job
Columbia Threadneedle Investments
Boston, MA; Minneapolis, MN ,United States of America
Sr Investment Risk Analyst Job gp
Franklin Templeton Investments
New York, NY ,United States of America
Investment Analyst - Public Equity Job lp
North Carolina Retirement Systems
Wake County, NC ,United States of America
Investment Analyst Job lp
Johns Hopkins University Endowment
Baltimore, MD ,United States of America
Similar Jobs
Firms you might be interested in
Numeric Investors LLC
Fund Manager
News
Adoption Of Symphonyrm's Ai-powered "next Best Actions" Soars As Company Doubles Revenue And Client Base And Raises $10M In Series A Financing
Adoption of SymphonyRM's AI-Powered "Next Best Actions" Soars as Company Doubles Revenue and Client Base and Raises $10 Million in Series A Financing Funding underscores healthcare's demand for the company's data science-driven CRM to deliver personalized, prioritized, and proactive consumer engagement PALO ALTO, Calif., May 16, 2019-- SymphonyRM, Healthcare's Next Best Action (NBA) company, today announced that it has doubled its revenue and client base year over year. To date, SymphonyRM's platform has generated more than $400 million in value … Full investment news article
Relevent to this post: Adams Street Partners
Alpha Venture Partners,
Storm Therapeutics Extends Series A To GBP 30m (usd 38.43m) With New Investor, Seroba Life Sciences
CAMBRIDGE, England, May 20, 2019-- STORM Therapeutics ("STORM"), the drug discovery company tackling disease through modulating RNA modifying enzymes, today announced that it has raised an additional £14 million bringing the total Series A financing to £30 million. The financing includes funding from new investor, Seroba Life Sciences ("Seroba"). STORM's existing investors, Cambridge Innovation Capital, M Ventures, Pfizer Ventures, Taiho Ventures and IP Group also participated in the fundraise. This extension follows the company's rapid progress to date. Full investment news article
Relevent to this post:
University of Nebraska Foundation,